Drägerwerk AG & Co. KGaA (pref) (DRW3) - Total Liabilities

Latest as of March 2026: €1.51 Billion EUR ≈ $1.76 Billion USD

Based on the latest financial reports, Drägerwerk AG & Co. KGaA (pref) (DRW3) has total liabilities worth €1.51 Billion EUR (≈ $1.76 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Drägerwerk AG & Co. KGaA (pref) (DRW3) long-term investment share to see how much of total assets are deployed in long-term investments.

Drägerwerk AG & Co. KGaA (pref) - Total Liabilities Trend (2013–2025)

This chart illustrates how Drägerwerk AG & Co. KGaA (pref)'s total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Drägerwerk AG & Co. KGaA (pref) total assets.

Drägerwerk AG & Co. KGaA (pref) Competitors by Total Liabilities

The table below lists competitors of Drägerwerk AG & Co. KGaA (pref) ranked by their total liabilities.

Company Country Total Liabilities
Terveystalo Oy
HE:TTALO
Finland €854.50 Million
Aevis Victoria SA
SW:AEVS
Switzerland CHF1.34 Billion
Goldsun Building Materials Co Ltd
TW:2504
Taiwan NT$23.15 Billion
Altus Group Limited
TO:AIF
Canada CA$537.21 Million
Nokian Renkaat Oyj
HE:TYRES
Finland €1.30 Billion
Playtech plc
F:PL8
Germany €823.30 Million
MilDef Group AB
ST:MILDEF
Sweden Skr1.53 Billion
BHI Co. Ltd
KQ:083650
Korea ₩719.46 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Drägerwerk AG & Co. KGaA (pref)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Drägerwerk AG & Co. KGaA (pref) (DRW3) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.07 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.91 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.48 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Drägerwerk AG & Co. KGaA (pref)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Drägerwerk AG & Co. KGaA (pref) (2013–2025)

The table below shows the annual total liabilities of Drägerwerk AG & Co. KGaA (pref) from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 €1.53 Billion
≈ $1.79 Billion
-1.43%
2024-12-31 €1.56 Billion
≈ $1.82 Billion
-7.64%
2023-12-31 €1.69 Billion
≈ $1.97 Billion
-5.70%
2022-12-31 €1.79 Billion
≈ $2.09 Billion
-6.81%
2021-12-31 €1.92 Billion
≈ $2.24 Billion
-15.60%
2020-12-31 €2.27 Billion
≈ $2.66 Billion
+52.03%
2019-12-31 €1.49 Billion
≈ $1.75 Billion
+12.41%
2018-12-31 €1.33 Billion
≈ $1.55 Billion
+3.39%
2017-12-31 €1.29 Billion
≈ $1.50 Billion
-1.74%
2016-12-31 €1.31 Billion
≈ $1.53 Billion
-4.15%
2015-12-31 €1.37 Billion
≈ $1.60 Billion
+2.09%
2014-12-31 €1.34 Billion
≈ $1.56 Billion
+7.08%
2013-12-31 €1.25 Billion
≈ $1.46 Billion
--

About Drägerwerk AG & Co. KGaA (pref)

F:DRW3 Germany Medical Devices
Market Cap
$1.13 Billion
€966.64 Million EUR
Market Cap Rank
#8345 Global
#1102 in Germany
Share Price
€112.40
Change (1 day)
+0.90%
52-Week Range
€62.30 - €115.20
All Time High
€115.20
About

Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas m… Read more